Global Hepatitis B Vaccines Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Hepatitis B Vaccines Market
Hepatitis B vaccine is a vaccine that prevents hepatitis B.

Due to the COVID-19 pandemic, the global Hepatitis B Vaccines market size is estimated to be worth US$ 1041.8 million in 2022 and is forecast to a readjusted size of US$ 1159.5 million by 2028 with a CAGR of 1.8% during the review period. Fully considering the economic change by this health crisis, Yeast Derived accounting for % of the Hepatitis B Vaccines global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Children segment is altered to an % CAGR throughout this forecast period.

In the last several years, Global market of Hepatitis B vaccine developed smoothly, with an average growth rate of -0.32%.

The classification of Hepatitis B vaccine includes Yeast Derived, CHO Derived, and the sales proportion of Yeast Derived in 2019 is about 97%. Hepatitis B vaccine is widely used for Children and Adult. About 84% of Hepatitis B vaccine is used for Children.

Asia-Pacific is the largest consumption place, with a consumption market share nearly 50% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of nearly 30%.

Market competition is intense. GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Yeast Derived

CHO Derived

Segment by Application

Children

Adult

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Hepatitis B Vaccines market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

GSK

NCPC

Merck

Bio Kangtai

Dynavax

Hissen

KM Biologics

LG Life Sciences

Serum Institute

TABLE OF CONTENT

1 Study Coverage
1.1 Hepatitis B Vaccines Product Introduction

1.2 Market by Type

1.2.1 Global Hepatitis B Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Yeast Derived

1.2.3 CHO Derived

1.3 Market by Application

1.3.1 Global Hepatitis B Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Children

1.3.3 Adult

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Hepatitis B Vaccines Sales Estimates and Forecasts 2017-2028

2.2 Global Hepatitis B Vaccines Revenue Estimates and Forecasts 2017-2028

2.3 Global Hepatitis B Vaccines Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Hepatitis B Vaccines Sales by Region

2.4.1 Global Hepatitis B Vaccines Sales by Region (2017-2022)

2.4.2 Global Sales Hepatitis B Vaccines by Region (2023-2028)

2.5 Global Hepatitis B Vaccines Revenue by Region

2.5.1 Global Hepatitis B Vaccines Revenue by Region (2017-2022)

2.5.2 Global Hepatitis B Vaccines Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Hepatitis B Vaccines Sales by Manufacturers

3.1.1 Global Top Hepatitis B Vaccines Manufacturers by Sales (2017-2022)

3.1.2 Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hepatitis B Vaccines in 2021

3.2 Global Hepatitis B Vaccines Revenue by Manufacturers

3.2.1 Global Hepatitis B Vaccines Revenue by Manufacturers (2017-2022)

3.2.2 Global Hepatitis B Vaccines Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Hepatitis B Vaccines Revenue in 2021

3.3 Global Hepatitis B Vaccines Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Hepatitis B Vaccines Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Hepatitis B Vaccines Sales by Type

4.1.1 Global Hepatitis B Vaccines Historical Sales by Type (2017-2022)

4.1.2 Global Hepatitis B Vaccines Forecasted Sales by Type (2023-2028)

4.1.3 Global Hepatitis B Vaccines Sales Market Share by Type (2017-2028)

4.2 Global Hepatitis B Vaccines Revenue by Type

4.2.1 Global Hepatitis B Vaccines Historical Revenue by Type (2017-2022)

4.2.2 Global Hepatitis B Vaccines Forecasted Revenue by Type (2023-2028)

4.2.3 Global Hepatitis B Vaccines Revenue Market Share by Type (2017-2028)

4.3 Global Hepatitis B Vaccines Price by Type

4.3.1 Global Hepatitis B Vaccines Price by Type (2017-2022)

4.3.2 Global Hepatitis B Vaccines Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Hepatitis B Vaccines Sales by Application

5.1.1 Global Hepatitis B Vaccines Historical Sales by Application (2017-2022)

5.1.2 Global Hepatitis B Vaccines Forecasted Sales by Application (2023-2028)

5.1.3 Global Hepatitis B Vaccines Sales Market Share by Application (2017-2028)

5.2 Global Hepatitis B Vaccines Revenue by Application

5.2.1 Global Hepatitis B Vaccines Historical Revenue by Application (2017-2022)

5.2.2 Global Hepatitis B Vaccines Forecasted Revenue by Application (2023-2028)

5.2.3 Global Hepatitis B Vaccines Revenue Market Share by Application (2017-2028)

5.3 Global Hepatitis B Vaccines Price by Application

5.3.1 Global Hepatitis B Vaccines Price by Application (2017-2022)

5.3.2 Global Hepatitis B Vaccines Price Forecast by Application (2023-2028)

6 North America

6.1 North America Hepatitis B Vaccines Market Size by Type

6.1.1 North America Hepatitis B Vaccines Sales by Type (2017-2028)

6.1.2 North America Hepatitis B Vaccines Revenue by Type (2017-2028)

6.2 North America Hepatitis B Vaccines Market Size by Application

6.2.1 North America Hepatitis B Vaccines Sales by Application (2017-2028)

6.2.2 North America Hepatitis B Vaccines Revenue by Application (2017-2028)

6.3 North America Hepatitis B Vaccines Market Size by Country

6.3.1 North America Hepatitis B Vaccines Sales by Country (2017-2028)

6.3.2 North America Hepatitis B Vaccines Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Hepatitis B Vaccines Market Size by Type

7.1.1 Europe Hepatitis B Vaccines Sales by Type (2017-2028)

7.1.2 Europe Hepatitis B Vaccines Revenue by Type (2017-2028)

7.2 Europe Hepatitis B Vaccines Market Size by Application

7.2.1 Europe Hepatitis B Vaccines Sales by Application (2017-2028)

7.2.2 Europe Hepatitis B Vaccines Revenue by Application (2017-2028)

7.3 Europe Hepatitis B Vaccines Market Size by Country

7.3.1 Europe Hepatitis B Vaccines Sales by Country (2017-2028)

7.3.2 Europe Hepatitis B Vaccines Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Hepatitis B Vaccines Market Size by Type

8.1.1 Asia Pacific Hepatitis B Vaccines Sales by Type (2017-2028)

8.1.2 Asia Pacific Hepatitis B Vaccines Revenue by Type (2017-2028)

8.2 Asia Pacific Hepatitis B Vaccines Market Size by Application

8.2.1 Asia Pacific Hepatitis B Vaccines Sales by Application (2017-2028)

8.2.2 Asia Pacific Hepatitis B Vaccines Revenue by Application (2017-2028)

8.3 Asia Pacific Hepatitis B Vaccines Market Size by Region

8.3.1 Asia Pacific Hepatitis B Vaccines Sales by Region (2017-2028)

8.3.2 Asia Pacific Hepatitis B Vaccines Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Hepatitis B Vaccines Market Size by Type

9.1.1 Latin America Hepatitis B Vaccines Sales by Type (2017-2028)

9.1.2 Latin America Hepatitis B Vaccines Revenue by Type (2017-2028)

9.2 Latin America Hepatitis B Vaccines Market Size by Application

9.2.1 Latin America Hepatitis B Vaccines Sales by Application (2017-2028)

9.2.2 Latin America Hepatitis B Vaccines Revenue by Application (2017-2028)

9.3 Latin America Hepatitis B Vaccines Market Size by Country

9.3.1 Latin America Hepatitis B Vaccines Sales by Country (2017-2028)

9.3.2 Latin America Hepatitis B Vaccines Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Hepatitis B Vaccines Market Size by Type

10.1.1 Middle East and Africa Hepatitis B Vaccines Sales by Type (2017-2028)

10.1.2 Middle East and Africa Hepatitis B Vaccines Revenue by Type (2017-2028)

10.2 Middle East and Africa Hepatitis B Vaccines Market Size by Application

10.2.1 Middle East and Africa Hepatitis B Vaccines Sales by Application (2017-2028)

10.2.2 Middle East and Africa Hepatitis B Vaccines Revenue by Application (2017-2028)

10.3 Middle East and Africa Hepatitis B Vaccines Market Size by Country

10.3.1 Middle East and Africa Hepatitis B Vaccines Sales by Country (2017-2028)

10.3.2 Middle East and Africa Hepatitis B Vaccines Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 GSK

11.1.1 GSK Corporation Information

11.1.2 GSK Overview

11.1.3 GSK Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 GSK Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 GSK Recent Developments

11.2 NCPC

11.2.1 NCPC Corporation Information

11.2.2 NCPC Overview

11.2.3 NCPC Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 NCPC Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 NCPC Recent Developments

11.3 Merck

11.3.1 Merck Corporation Information

11.3.2 Merck Overview

11.3.3 Merck Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Merck Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Merck Recent Developments

11.4 Bio Kangtai

11.4.1 Bio Kangtai Corporation Information

11.4.2 Bio Kangtai Overview

11.4.3 Bio Kangtai Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Bio Kangtai Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Bio Kangtai Recent Developments

11.5 Dynavax

11.5.1 Dynavax Corporation Information

11.5.2 Dynavax Overview

11.5.3 Dynavax Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Dynavax Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Dynavax Recent Developments

11.6 Hissen

11.6.1 Hissen Corporation Information

11.6.2 Hissen Overview

11.6.3 Hissen Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Hissen Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Hissen Recent Developments

11.7 KM Biologics

11.7.1 KM Biologics Corporation Information

11.7.2 KM Biologics Overview

11.7.3 KM Biologics Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 KM Biologics Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 KM Biologics Recent Developments

11.8 LG Life Sciences

11.8.1 LG Life Sciences Corporation Information

11.8.2 LG Life Sciences Overview

11.8.3 LG Life Sciences Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 LG Life Sciences Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 LG Life Sciences Recent Developments

11.9 Serum Institute

11.9.1 Serum Institute Corporation Information

11.9.2 Serum Institute Overview

11.9.3 Serum Institute Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Serum Institute Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Serum Institute Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Hepatitis B Vaccines Industry Chain Analysis

12.2 Hepatitis B Vaccines Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Hepatitis B Vaccines Production Mode & Process

12.4 Hepatitis B Vaccines Sales and Marketing

12.4.1 Hepatitis B Vaccines Sales Channels

12.4.2 Hepatitis B Vaccines Distributors

12.5 Hepatitis B Vaccines Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Hepatitis B Vaccines Industry Trends

13.2 Hepatitis B Vaccines Market Drivers

13.3 Hepatitis B Vaccines Market Challenges

13.4 Hepatitis B Vaccines Market Restraints

14 Key Findings in The Global Hepatitis B Vaccines Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample